John D. Baxter Prize for Entrepreneurship

The John D. Baxter Prize for Entrepreneurship was established to recognize the extraordinary achievement of bringing an idea, product, service, or process to market; which ultimately elevates the field of endocrinology, and positively impacts the health of patients.

The award recipient of the Baxter Prize receives a $50,000 award, the John D. Baxter Medal for Entrepreneurship, and global acclaim. The winner will be awarded at the Society's annual meeting ENDO 2023, June 15-18, 2023, Chicago, IL, the largest gathering in the world of endocrinologist and professionals working in hormone health.

Call for Nominations for the 2023 John D. Baxter Prize open Tuesday, July 26, 2022. The deadline to receive all nominations is Friday, September 16, 2022.

Award Winners

Eligibility Criteria 

• Nominee(s) must have demonstrated a record of scientific innovation as evidenced by research that has resulted in the development of new products, techniques or approaches to diagnostic or therapeutic patient care in the field of endocrinology.
• Nominee(s) must be established career scientists and/or clinicians whose work has significantly advanced the translation of research findings to patient care.
• Teams of scientists/entrepreneurs are eligible, with one team member designated as the lead nominee.
• Self-nominations are accepted and encouraged. 
• Nominees are not required to be Endocrine Society members, although membership is strongly encouraged.
• The Baxter Prize will not be awarded posthumously.

Nomination Instructions

Nomination packages must be submitted as a single file in the nomination form and must include:

• The nominee's responses to the Baxter Prize Application Question
• Three letters of support from the nominees' colleagues (each letter not to exceed one page)
• List of any patents held by the nominee
• The nominee's CV and/or resume

Background

John D. Baxter, MD, was a renowned endocrinologist who rose to prominence as a researcher with breakthroughs in molecular biology and early recombinant DNA technology, leading to the first successful gene cloning for rat, bovine, and human growth hormone. His dedication to scientific and clinical research garnered numerous awards and recognition. As President of the Endocrine Society from 2002 – 2003, Dr. Baxter shared his passion for advancing research that would lead to effective clinical applications.